Patents by Inventor Alexandre LARANGE

Alexandre LARANGE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for the isolation and/or generation of specific CD4+ and CD8+ T-cell subsets
    Patent number: 11951128
    Abstract: The present disclosure relates to particular subsets of CD4+ and CD8+ T-cells, methods of isolating and generating these cells, compositions comprising these cells, and methods of treatment of a tumor or cancer by administering these cells alone or in combination with each other and/or additional therapies.
    Type: Grant
    Filed: August 2, 2018
    Date of Patent: April 9, 2024
    Assignee: LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY
    Inventors: Hilde Cheroutre, Nicolas Thiault, Alexandre Larange, Hitoshi Iwaya
  • COMPOSITIONS AND METHODS FOR THE ISOLATION AND/OR GENERATION OF SPECIFIC CD4+ AND CD8+ T-CELL SUBSETS
    Publication number: 20210128614
    Abstract: The present disclosure relates to particular subsets of CD4+ and CD8+ T-cells, methods of isolating and generating these cells, compositions comprising these cells, and methods of treatment of a tumor or cancer by administering these cells alone or in combination with each other and/or additional therapies.
    Type: Application
    Filed: August 2, 2018
    Publication date: May 6, 2021
    Applicant: La Jolla Institute for Allergy and Immunology
    Inventors: Hilde CHEROUTRE, Nicolas THIAULT, Alexandre LARANGE, Hitoshi IWAYA